Assignee
COSMO TECHNOLOGIES LTD
IE·30 granted patents·30 pending applications·285 citations·filing 2000–2025
Top patents by PatentIndex Score
60 records- 0198US7410651B2Controlled release and taste masking oral pharmaceutical compositionCOSMO TECHNOLOGIES LTD·Filed 2005·Granted Aug 12, 2008·51 cites·11 claims
- 0297US8029823B2Controlled release and taste masking oral pharmaceutical compositionCOSMO TECHNOLOGIES LTD·Filed 2008·Granted Oct 4, 2011·32 cites·11 claims
- 0396US9192581B2Controlled release and taste masking oral pharmaceutical compositionCOSMO TECHNOLOGIES LTD·Filed 2014·Granted Nov 24, 2015·13 cites·32 claims
- 0496US7410652B2Controlled release and taste masking oral pharmaceutical compositionCOSMO TECHNOLOGIES LTD·Filed 2006·Granted Aug 12, 2008·32 cites·4 claims
- 0595US9364580B2Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissectionCOSMO TECHNOLOGIES LTD·Filed 2015·Granted Jun 14, 2016·17 cites·24 claims
- 0695US7431943B1Controlled release and taste masking oral pharmaceutical compositionsCOSMO TECHNOLOGIES LTD·Filed 2000·Granted Oct 7, 2008·78 cites·13 claims
- 0794US9320716B2Controlled release and taste masking oral pharmaceutical compositionsCOSMO TECHNOLOGIES LTD·Filed 2014·Granted Apr 26, 2016·12 cites·29 claims
- 0894US9226996B2Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissectionCOSMO TECHNOLOGIES LTD·Filed 2014·Granted Jan 5, 2016·23 cites·14 claims
- 0993US9522216B2Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissectionCOSMO TECHNOLOGIES LTD·Filed 2016·Granted Dec 20, 2016·12 cites·24 claims
- 1091US11986484B217α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumorsCOSMO TECHNOLOGIES LTD·Filed 2022·Granted May 21, 2024·1 cites·3 claims
- 1186US11712443B217α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumorsCOSMO TECHNOLOGIES LTD·Filed 2021·Granted Aug 1, 2023·1 cites·6 claims
- 1285US9962445B2Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissectionCOSMO TECHNOLOGIES LTD·Filed 2016·Granted May 8, 2018·3 cites·20 claims
- 1385US2024277731A117a-monoesters and 17a,21-diesters of cortexolone for use in the treatment of tumorsCOSMO TECHNOLOGIES LTD·Filed 2024·Application pending·0 cites
- 1483US10413611B2Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissectionCOSMO TECHNOLOGIES LTD·Filed 2018·Granted Sep 17, 2019·2 cites·15 claims
- 1583US9592203B2Controlled release and taste masking oral pharmaceutical compositionCOSMO TECHNOLOGIES LTD·Filed 2016·Granted Mar 14, 2017·1 cites·25 claims
- 1683US9532954B2Controlled release and taste masking oral pharmaceutical compositionsCOSMO TECHNOLOGIES LTD·Filed 2014·Granted Jan 3, 2017·2 cites·38 claims
- 1782US10993949B217α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumorsCOSMO TECHNOLOGIES LTD·Filed 2020·Granted May 4, 2021·1 cites·2 claims
- 1882US9987366B2Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissectionCOSMO TECHNOLOGIES LTD·Filed 2014·Granted Jun 5, 2018·3 cites·49 claims
- 1980US12036316B2Oral rifamycin SV compositionsCOSMO TECHNOLOGIES LTD·Filed 2022·Granted Jul 16, 2024·0 cites·20 claims
- 2080US2024398699A1Oral rifamycin sv compositionsCOSMO TECHNOLOGIES LTD·Filed 2024·Application pending·0 cites
- 2179US2023130628A1Solid oral composition containing dyes for use in endoscopic diagnosisCOSMO TECHNOLOGIES LTD·Filed 2022·Application pending·0 cites
- 2278US10849979B2Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissectionCOSMO TECHNOLOGIES LTD·Filed 2019·Granted Dec 1, 2020·0 cites·20 claims
- 2377US10646497B217α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumorsCOSMO TECHNOLOGIES LTD·Filed 2018·Granted May 12, 2020·1 cites·9 claims
- 2476US2020268909A1Solid composition for the oral administration of dyes and diagnostic use thereofCOSMO TECHNOLOGIES LTD·Filed 2019·Application pending·0 cites
- 2573US2020129643A1Solid oral composition containing dyes for use in endoscopic diagnosisCOSMO TECHNOLOGIES LTD·Filed 2019·Application pending·0 cites
- 2672US2021093576A1Oral antimicrobial pharmaceutical compositionsCOSMO TECHNOLOGIES LTD·Filed 2020·Application pending·0 cites
- 2771US2025186626A1Solid oral composition containing dyes for use in endoscopic diagnosisCOSMO TECHNOLOGIES LTD·Filed 2025·Application pending·0 cites
- 2870US9737489B2Controlled release and taste masking oral pharmaceutical compositionCOSMO TECHNOLOGIES LTD·Filed 2016·Granted Aug 22, 2017·0 cites·18 claims
- 2970US9402923B2Solid composition for the oral administration of dyes and diagnostic use thereofCOSMO TECHNOLOGIES LTD·Filed 2013·Granted Aug 2, 2016·0 cites·19 claims
- 3070US2015056279A1Controlled Release and Taste Masking Oral Pharmaceutical CompositionsCOSMO TECHNOLOGIES LTD·Filed 2014·Application pending·0 cites
- 3169US11564883B2Oral rifamycin SV compositionsCOSMO TECHNOLOGIES LTD·Filed 2018·Granted Jan 31, 2023·0 cites·18 claims
- 3269US9402922B2Solid composition for the oral administration of dyes and diagnostic use thereofCOSMO TECHNOLOGIES LTD·Filed 2013·Granted Aug 2, 2016·0 cites·28 claims
- 3368US11123460B2Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissectionCOSMO TECHNOLOGIES LTD·Filed 2019·Granted Sep 21, 2021·0 cites·19 claims
- 3468US2015283268A1Solid oral composition containing dyes for use in endoscopic diagnosisCOSMO TECHNOLOGIES LTD·Filed 2013·Application pending·0 cites
- 3567US2019192441A1Oral antimicrobial pharmaceutical compositionsCOSMO TECHNOLOGIES LTD·Filed 2019·Application pending·0 cites
- 3666US2013053360A1Controlled release and taste masking oral pharmaceutical compositionCOSMO TECHNOLOGIES LTD·Filed 2012·Application pending·0 cites
- 3765US2015352128A1Controlled release and taste masking oral pharmaceutical compositionCOSMO TECHNOLOGIES LTD·Filed 2015·Application pending·0 cites
- 3865US2024299551A1Liquid delivery compositionCOSMO TECHNOLOGIES LTD·Filed 2024·Application pending·0 cites
- 3965US2019175618A117alpha-monoesters of cortexolone for use in the treatment of tumorsCOSMO TECHNOLOGIES LTD·Filed 2019·Application pending·0 cites
- 4064US2015010639A1Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disordersCOSMO TECHNOLOGIES LTD·Filed 2014·Application pending·0 cites
- 4164US2008233193A1Oral antimicrobial pharmaceutical compositionsCOSMO TECHNOLOGIES LTD·Filed 2008·Application pending·0 cites
- 4264US2014370093A1Oral antimicrobial pharmaceutical compositionsCOSMO TECHNOLOGIES LTD·Filed 2014·Application pending·0 cites
- 4360US2018214580A1Solid composition for the oral administration of dyes and diagnostic use thereofCOSMO TECHNOLOGIES LTD·Filed 2018·Application pending·0 cites
- 4458US10265420B2Solid composition for the oral administration of dyes and diagnostic use thereofCOSMO TECHNOLOGIES LTD·Filed 2016·Granted Apr 23, 2019·0 cites·27 claims
- 4558US10231980B2Cortexolone 17alpha-benzoate for use in the treatment of tumoursCOSMO TECHNOLOGIES LTD·Filed 2015·Granted Mar 19, 2019·0 cites·14 claims
- 4658US10183030B217α,21-diesters of cortexolone for use in the treatment of tumorsCOSMO TECHNOLOGIES LTD·Filed 2015·Granted Jan 22, 2019·0 cites·5 claims
- 4758US2007128266A1Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disordersCOSMO TECHNOLOGIES LTD·Filed 2005·Application pending·0 cites
- 4858US2020061212A1Solid oral composition containing dyesCOSMO TECHNOLOGIES LTD·Filed 2017·Application pending·0 cites
- 4958US2013209559A1Method for treating intestinal diseases presenting at least one inflammatory componentCOSMO TECHNOLOGIES LTD·Filed 2013·Application pending·0 cites
- 5058US2018147301A1Solid oral composition containing dyesCOSMO TECHNOLOGIES LTD·Filed 2017·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →